文献速递显微修复重建瘢痕与激光

缓激肽B2受体对大鼠多 Territory 穿支皮瓣存活的影响

The Effect of Bradykinin B2 Receptor on Multiterritory Perforator Flap Survival in Rats: An Experimental Study.
PubMed 文献 · Ann Plast Surg · 2025-12-19

研究探讨缓激肽B2受体(B2R)对穿支皮瓣存活的作用,将50只雄性SD大鼠分为B2R阻滞剂组和对照组,均行皮瓣手术。结果显示阻滞剂组皮瓣存活面积、血流灌注和新生血管均显著降低,自噬、凋亡和氧化应激增加,提示B2R通过多途径保护皮瓣。

要点

  • B2R阻滞后皮瓣存活面积从85.6%降至64.7%,血流灌注和新生血管减少。
  • B2R阻滞导致SOD活性、NO含量和VEGF表达降低,MDA升高,自噬和凋亡增加。
  • B2R可能通过抑制凋亡、抗氧化、调节自噬和促进血管生成保护多 Territory 穿支皮瓣。

核心结论

  • 缓激肽B2受体通过抑制凋亡、抗氧化、调节自噬和促进血管生成等多条分子通路保护多 Territory 穿支皮瓣,改善皮瓣血供。

研究设计与样本

  • 实验性研究,50只雄性Sprague-Dawley大鼠均分为B2R阻滞剂组和对照组,两组均行皮瓣手术。

主要发现

  • B2R阻滞剂组皮瓣存活面积显著低于对照组(64.7 ± 3.36% vs 85.6 ± 3.35%,P < 0.01)。
  • B2R阻滞剂组血流灌注显著低于对照组(389.8 ± 7.92 vs 491.8 ± 5.81,P < 0.05)。
  • B2R阻滞剂组新生血管显著少于对照组(20.13 ± 1.58 vs 52.17 ± 1.49,P < 0.05)。
  • B2R阻滞剂组SOD活性、NO含量和VEGF表达降低,MDA水平升高(均P < 0.05)。
  • B2R阻滞剂组自噬和凋亡水平高于对照组。

临床怎么用

  • 提示缓激肽B2受体可能成为改善多 Territory 穿支皮瓣存活的潜在干预靶点,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The bradykinin B2 receptor (B2R), a type of G protein-coupled receptor, exerts several beneficial biological effects on flaps. Accordingly, we investigated the role of the bradykinin B2R in the survival of perforator flaps. METHODS: In this study, a total of 50 male Sprague-Dawley rats were allocated equally into 2 groups: one receiving a bradykinin B2R blocker and the other serving as a control, with both groups undergoing flap procedures. Flap viability was assessed 7 days postoperatively by quantifying the surviving flap area. Blood perfusion within the flap was evaluated using laser Doppler imaging. The levels of Beclin-1, p62, and LC3-II/I were used to assess autophagy. The extent of flap angiogenesis was evaluated using immunohistochemistry and hematoxylin and eosin staining. Western blotting revealed the expression levels of vascular endothelial growth factor (VEGF) and the apoptotic index. Moreover, superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels were used to evaluate oxidative stress. This study used a nitric oxide (NO) assay kit to determine NO production. RESULTS: The bradykinin B2R blocker group exhibited significantly reduced flap survival areas (blocker group: 64.7 ± 3.36%; control group: 85.6 ± 3.35%; P < 0.01), diminished blood perfusion (blocker group: 389.8 ± 7.92; control group: 491.8 ± 5.81; P < 0.05), and decreased neovascularization (blocker group: 20.13 ± 1.58; control group: 52.17 ± 1.49; P < 0.05). Compared to the control group, the bradykinin B2R blocker group also demonstrated lower SOD activity, NO content, and VEGF expression, and increased MDA levels (all P < 0.05). Rats treated with the bradykinin B2R blocker exhibited higher levels of autophagy and apoptosis than those observed in the control group. CONCLUSION: According to our research, the bradykinin B2R protects multiterritory perforator flaps through diverse molecular pathways, which involve inhibiting apoptosis, combating oxidation, modulating autophagy, and fostering angiogenesis to improve the blood supply to the flap.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Wang J, Ye M. The Effect of Bradykinin B2 Receptor on Multiterritory Perforator Flap Survival in Rats: An Experimental Study. Ann Plast Surg. 2025. PMID: 41418072. doi:10.1097/SAP.0000000000004598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。